Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 548

1.

Managing statin myopathy.

Venero CV, Thompson PD.

Endocrinol Metab Clin North Am. 2009 Mar;38(1):121-36. doi: 10.1016/j.ecl.2008.11.002. Review.

PMID:
19217515
2.

Statin-associated myopathy.

Hamilton-Craig I.

Med J Aust. 2001 Nov 5;175(9):486-9. Review.

PMID:
11758079
4.

Statin-induced myopathies.

Tomaszewski M, Stępień KM, Tomaszewska J, Czuczwar SJ.

Pharmacol Rep. 2011;63(4):859-66. Review.

5.

Managing the underestimated risk of statin-associated myopathy.

Rallidis LS, Fountoulaki K, Anastasiou-Nana M.

Int J Cardiol. 2012 Sep 6;159(3):169-76. doi: 10.1016/j.ijcard.2011.07.048. Epub 2011 Aug 2. Review.

PMID:
21813193
6.

Narrative review: statin-related myopathy.

Joy TR, Hegele RA.

Ann Intern Med. 2009 Jun 16;150(12):858-68. Review.

PMID:
19528564
7.

[Creatine kinase increase under simvastatin--therapeutic consequences?].

Rasche-Schürmann CC, Picksak G, Stichtenoth DO.

Med Monatsschr Pharm. 2008 Jan;31(1):25-7. German.

PMID:
18522017
8.

[Muscle problems due to statins: underestimated].

Janssen SP, Smulders YM, Gerdes VE, Visseren FL.

Ned Tijdschr Geneeskd. 2010;154:A1684. Review. Dutch.

PMID:
21435278
9.

Outcomes in 45 patients with statin-associated myopathy.

Hansen KE, Hildebrand JP, Ferguson EE, Stein JH.

Arch Intern Med. 2005 Dec 12-26;165(22):2671-6.

PMID:
16344427
10.

Statin-associated myopathy with normal creatine kinase levels.

Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ, Vladutiu GD, England JD; Scripps Mercy Clinical Research Center.

Ann Intern Med. 2002 Oct 1;137(7):581-5.

PMID:
12353945
11.

The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.

Harper CR, Jacobson TA.

Curr Opin Lipidol. 2007 Aug;18(4):401-8. Review.

PMID:
17620856
12.

Managing statin-induced muscle toxicity in a lipid clinic.

Blaier O, Lishner M, Elis A.

J Clin Pharm Ther. 2011 Jun;36(3):336-41. doi: 10.1111/j.1365-2710.2011.01254.x. Epub 2011 Mar 18.

PMID:
21414023
13.

Clinical characterization and molecular mechanisms of statin myopathy.

Toth PP, Harper CR, Jacobson TA.

Expert Rev Cardiovasc Ther. 2008 Aug;6(7):955-69. doi: 10.1586/14779072.6.7.955. Review.

PMID:
18666846
14.

Muscle symptoms associated with statins: a series of twenty patients.

Soininen K, Niemi M, Kilkki E, Strandberg T, Kivistö KT.

Basic Clin Pharmacol Toxicol. 2006 Jan;98(1):51-4.

15.

Myotoxicity associated with lipid-lowering drugs.

Baer AN, Wortmann RL.

Curr Opin Rheumatol. 2007 Jan;19(1):67-73. Review.

PMID:
17143099
16.

[Statin myopathy--rarity or reality?].

Pella D.

Vnitr Lek. 2010 Sep;56(9 Suppl):972-6. Review. Slovak.

PMID:
21137170
17.

Risks associated with statin therapy: a systematic overview of randomized clinical trials.

Kashani A, Phillips CO, Foody JM, Wang Y, Mangalmurti S, Ko DT, Krumholz HM.

Circulation. 2006 Dec 19;114(25):2788-97. Epub 2006 Dec 11. Review.

18.

Genetic predisposition to statin myopathy.

Vladutiu GD.

Curr Opin Rheumatol. 2008 Nov;20(6):648-55. doi: 10.1097/BOR.0b013e328314b7b4. Review.

PMID:
18946323
19.

Statin-induced apoptosis and skeletal myopathy.

Dirks AJ, Jones KM.

Am J Physiol Cell Physiol. 2006 Dec;291(6):C1208-12. Epub 2006 Aug 2. Review.

PMID:
16885396
20.

Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care setting.

Smith CC, Bernstein LI, Davis RB, Rind DM, Shmerling RH.

Arch Intern Med. 2003 Mar 24;163(6):688-92.

PMID:
12639201

Supplemental Content

Support Center